The Variability of Amino Acid Sequences in Hepatitis B Virus.
Amino acid
Hepatitis B virus (HBV)
Sequence characterization
Variability and conservation
Journal
Virologica Sinica
ISSN: 1995-820X
Titre abrégé: Virol Sin
Pays: Netherlands
ID NLM: 101514185
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
16
07
2018
accepted:
13
11
2018
pubmed:
6
1
2019
medline:
30
4
2019
entrez:
6
1
2019
Statut:
ppublish
Résumé
Hepatitis B virus (HBV) is an important human pathogen belonging to the Hepadnaviridae family, Orthohepadnavirus genus. Over 240 million people are infected with HBV worldwide. The reverse transcription during its genome replication leads to low fidelity DNA synthesis, which is the source of variability in the viral proteins. To investigate the variability quantitatively, we retrieved amino acid sequences of 5,167 records of all available HBV genotypes (A-J) from the Genbank database. The amino acid sequences encoded by the open reading frames (ORF) S/C/P/X in the HBV genome were extracted and subjected to alignment. We analyzed the variability of the lengths and the sequences of proteins as well as the frequencies of amino acids. It comprehensively characterized the variability and conservation of HBV proteins at the level of amino acids. Especially for the structural proteins, hepatitis B surface antigens (HBsAg), there are potential sites critical for virus assembly and immune recognition. Interestingly, the preS1 domains in HBsAg were variable at some positions of amino acid residues, which provides a potential mechanism of immune-escape for HBV, while the preS2 and S domains were conserved in the lengths of protein sequences. In the S domain, the cysteine residues and the secondary structures of the alpha-helix and beta-sheet were likely critical for the stable folding of all HBsAg components. Also, the preC domain and C-terminal domain of the core protein are highly conserved. However, the polymerases (HBpol) and the HBx were highly variable at the amino acid level. Our research provides a basis for understanding the conserved and important domains of HBV viral proteins, which could be potential targets for anti-virus therapy.
Identifiants
pubmed: 30610573
doi: 10.1007/s12250-018-0070-x
pii: 10.1007/s12250-018-0070-x
pmc: PMC6420546
doi:
Substances chimiques
Amino Acids
0
DNA, Viral
0
Hepatitis B Surface Antigens
0
Viral Proteins
0
Cysteine
K848JZ4886
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
42-49Références
J Mol Biol. 1999 Sep 17;292(2):195-202
pubmed: 10493868
Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68
pubmed: 10704474
J Virol. 2001 Dec;75(23):11565-72
pubmed: 11689638
Virus Res. 2004 Dec;106(2):199-209
pubmed: 15567498
J Mol Biol. 2009 Jul 3;390(1):135-41
pubmed: 19414021
J Virol. 2009 Dec;83(23):12443-51
pubmed: 19759159
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Elife. 2012 Nov 13;1:e00049
pubmed: 23150796
PLoS One. 2013 Sep 06;8(9):e69729
pubmed: 24039702
Virology. 2015 May;479-480:672-86
pubmed: 25759099
Curr Opin Virol. 2018 Jun;30:58-67
pubmed: 29751272
J Virol. 1984 Nov;52(2):396-402
pubmed: 6492255
JAMA. 1976 Jun 28;235(26):2832-4
pubmed: 819667
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9556-61
pubmed: 9275161